Skip to main content

Table 1 Patient characteristics of mutant and wild-type IDH groups

From: Accumulation of 2-hydroxyglutarate in gliomas correlates with survival: a study by 3.0-tesla magnetic resonance spectroscopy

Characteristic Number of patients (%) pvalue
  MutantIDH Wild-typeIDH  
Number 25 27  
Men: Women 14:11 14:13  
Age (years)    
Median 45 61 0.0008*
Range 26-67 28-77  
Newly diagnosed 22 (88.0) 25 (92.6) 0.9279
Recurrent 3 (12.0) 2 (7.4)  
Pathological grade    
WHO Grade II 17 (68.0) 7 (25.9) 0.0024*
WHO Grade III 8 (32.0) 20 (74.1)  
Outcome    
Alive 20 (80.0) 12 (44.4) 0.0085*
Dead 5 (20.0) 15 (55.6)  
  1. Results of unpaired t-test (age) and chi-squared tests (others). The values inside parentheses represent percentage of patients within each group.
  2. *p <0.05.
  3. IDH: isocitrate dehydrogenase; WHO: World Health Organization.